Bradley A. Stohr

Renal tumors harboring FLCN mutations: Case series from clinical practice

Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer

Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer

Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Metabolic imaging with hyperpolarized ¹³C pyruvate magnetic resonance imaging in patients with renal tumors—Initial experience

Broad Distribution of Hepatocyte Proliferation in Liver Homeostasis and Regeneration

Pathophysiology, Clinical Manifestations, and Treatment of Lichen Sclerosus: A Systematic Review

“Renal Cell Carcinoma With Leiomyomatous Stroma” Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity

Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors

Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors

Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity

The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres

Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells

The Role of Telomere Biology in Cancer